<DOC>
	<DOC>NCT01384643</DOC>
	<brief_summary>Ischemia/reperfusion (I/R)-induced acute kidney injury is a serious complication affecting patient outcome following cardiovascular surgeries. Propofol, an intravenously administered anesthetic with antioxidant properties, protects organs from I/R injury. This study aimed to investigate the ability of propofol to protect kidneys against I/R injury in the patients undergoing valvular heart surgery.</brief_summary>
	<brief_title>Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<criteria>Patients undergoing valvular heart surgery. Age: 20~75. Emergency operation. Patients with vitamin E or vitamin C within 5 days before surgery. Patients with preoperative Creactive protein (CRP) &gt; 16 mg/L. Patients with serum creatinine â‰¥ 2.0 mg/dL Patients under hemodialysis. Patients with acute myocardial infarction within 1 week before surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>